AUPH Valuation
Aurinia Pharmaceuticals Inc
$
8.210
- Overview
- Forecast
- Valuation
AUPH Relative Valuation
AUPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AUPH is overvalued; if below, it's undervalued.
Historical Valuation
Aurinia Pharmaceuticals Inc (AUPH) is now in the Fair zone, suggesting that its current forward PS ratio of 4.34 is considered Fairly compared with the five-year average of 58.46. The fair price of Aurinia Pharmaceuticals Inc (AUPH) is between 8.21 to 10.14 according to relative valuation methord.
Relative Value
Fair Zone
8.21-10.14
Current Price：8.21
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
3.06
P/B
Median3y
2.90
Median5y
4.11
3.93
FCF Yield
Median3y
-4.25
Median5y
-4.84
Competitors Valuation Multiple
The average P/S ratio for AUPH's competitors is 7.36, providing a benchmark for relative valuation. Aurinia Pharmaceuticals Inc Corp (AUPH) exhibits a P/S ratio of 4.34, which is -41.03% above the industry average. Given its robust revenue growth of 32.76%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
ACTG
Acacia Research Corp
3.160
USD
+0.32%
SNDA
Sonida Senior Living Inc
24.080
USD
+3.70%
DDD
3D Systems Corp
2.010
USD
+6.35%
JILL
JJill Inc
15.860
USD
+2.12%
CYD
China Yuchai International Ltd
16.610
USD
+8.56%
RWAY
Runway Growth Finance Corp
9.210
USD
+1.43%
HAIN
Hain Celestial Group Inc
3.030
USD
+3.77%
DCGO
DocGo Inc
2.310
USD
+5.00%
ZVRA
Zevra Therapeutics Inc
8.000
USD
+4.71%
YRD
Yiren Digital Ltd
6.380
USD
-2.60%
FAQ
Is Aurinia Pharmaceuticals Inc (AUPH) currently overvalued or undervalued?
Aurinia Pharmaceuticals Inc (AUPH) is now in the Fair zone, suggesting that its current forward PE ratio of 17.66 is considered Fairly compared with the five-year average of 58.46. The fair price of Aurinia Pharmaceuticals Inc (AUPH) is between 8.21 to 10.14 according to relative valuation methord.
What is Aurinia Pharmaceuticals Inc (AUPH) fair value?
How does AUPH's valuation metrics compare to the industry average?
What is the current P/B ratio for Aurinia Pharmaceuticals Inc (AUPH) as of May 04 2025?
What is the current FCF Yield for Aurinia Pharmaceuticals Inc (AUPH) as of May 04 2025?
What is the current Forward P/E ratio for Aurinia Pharmaceuticals Inc (AUPH) as of May 04 2025?